Pharmaceutical industry news
Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.
33,661 stories, page 5 of 562
🇺🇸Regulatoryfederalregister.gov
Order Under Sections 362 and 365 of the Public Health Service Act Continuing the Suspension of the Right To Introduce Certain Persons From Countries Where a Quarantinable Communicable Disease Exists
The Centers for Disease Control and Prevention (CDC), a component of the Department of Health and Hu...
Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.gov
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Biological Products: Reporting of Biological Product Deviations and Human Cells, Tissues, and Cellular and Tissue-Based Product Deviations in Manufacturing
The Food and Drug Administration (FDA, Agency, or we) is announcing that a proposed collection of in...
Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.gov
Proposed Collection; 60-Day Comment Request; NIH Intramural Reporting of Research Misconduct (IRRM) Web Form (Office of the Director/Office of Intramural Research)
The NIH Intramural Research Program (IRP) relies on a trustworthy research record to sustain public...
Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.gov
Microbiology Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Pathogen-Agnostic Sequencing
The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of...
Federal RegisterOriginal source
🌍Researchdoi.org
Figure 2 from: Nikolov D, Nikolov G, Kitova L, Kitov S, Kitova M-F, Mihaylova AA (2026) Rituximab therapy in severe PR3-ANCA pulmonary–renal syndrome: A clinical and pharmaceutical case report. Pharmacia 73: e201634. https://doi.org/10.3897/pharmacia.73.e201634
CrossrefOriginal source






